Tickers — D

66 tickers
Ranks this page's recent reports by score.
DexCom, Inc.
DXCM·Healthcare
A ★★★★Buy
Current$82.29
Target$95.20
Return+15.7%
Nov 1, 2026

Dexcom offers recurring CGM revenue, high capital returns, and substantial long-term diabetes-monitoring growth potential at a compressed historical valuation, although Abbott competition and reimbursement constraints could limit upside.

Score
84
Digital Realty Trust, Inc.
DLR·Real Estate
B ★★★Hold
Current$180.70
Target$198.00
Return+9.6%
Nov 1, 2026

Digital Realty offers durable exposure to growing AI and cloud data center demand through a global property platform and record leasing backlog, but high development spending, dilution, and a premium valuation constrain shareholder upside.

Score
69
Duke Energy Corporation
DUK·Utilities
B ★★★Hold
Current$127.39
Target$129.06
Return+1.3%
Nov 1, 2026

Duke Energy offers durable regulated electricity earnings, an established dividend, and growing power demand, but its $103B investment program and heavy financing needs constrain free cash flow and near-term valuation upside.

Score
66
DT Midstream, Inc.
DTM·Energy
B ★★★Hold
Current$124.34
Target$135.38
Return+8.9%
Nov 1, 2026

DT Midstream offers durable contracted natural gas infrastructure cash flows and growth from power demand, but elevated valuation and capital-intensive expansion limit its margin of safety.

Score
65
Dominion Energy, Inc.
D·Utilities
B ★★★Hold
Current$66.62
Target$70.20
Return+5.4%
Nov 1, 2026

Dominion Energy offers durable regulated utility earnings and data-center-driven electricity growth, but heavy debt, negative free cash flow, and major construction commitments constrain shareholder upside.

Score
65
D.R. Horton, Inc.
DHI·Consumer Discretionary
B ★★★Hold
Current$146.00
Target$140.25
Return-3.9%
Nov 1, 2026

D.R. Horton's national scale, resilient cash generation and aggressive buybacks support long-term per-share value, but persistent housing affordability pressure and declining margins limit near-term upside.

Score
66
Dana Incorporated
DAN·Consumer Discretionary
B ★★★Hold
Current$23.11
Target$31.50
Return+36.3%
Oct 31, 2026

Dana offers a potentially undervalued automotive-supplier turnaround supported by margin expansion, deleveraging, and Eaton Mobility synergies, but weak cash conversion and merger execution risks constrain conviction.

Score
71
Darling Ingredients Inc.
DAR·Consumer Staples
A ★★★★Buy
Current$55.73
Target$71.34
Return+28.0%
Oct 31, 2026

Darling Ingredients combines hard-to-replicate rendering infrastructure with improving renewable-fuel cash flows and debt reduction, offering attractive recovery upside despite volatile fuel margins and policy dependence.

Score
82
DHT Holdings, Inc.
DHT·Energy
B ★★★Hold
Current$25.02
Target$25.50
Return+1.9%
Oct 31, 2026

DHT combines exceptional VLCC freight earnings, strong cash generation, and shareholder distributions with a disciplined balance sheet, but cyclical rate normalization and elevated fleet valuations constrain long-term upside.

Score
71
Leonardo DRS, Inc.
DRS·Industrials
A ★★★★Buy
Current$37.68
Target$42.00
Return+11.5%
Oct 31, 2026

Leonardo DRS combines durable defense technology demand, rising backlog, and improving capital returns with long-term earnings growth potential, although government procurement concentration and demanding valuation limit its margin of safety.

Score
82
DoorDash, Inc.
DASH·Consumer Discretionary
A ★★★★Buy
Current$178.99
Target$201.35
Return+12.5%
Oct 31, 2026

DoorDash combines a scaled global local-commerce network with rapidly improving profitability and cash generation, but its proposed Instacart acquisition could introduce significant financing, dilution, and integration risks.

Score
76
DaVita Inc.
DVA·Healthcare
A ★★★★Buy
Current$187.50
Target$219.96
Return+17.3%
Oct 31, 2026

DaVita combines essential recurring dialysis demand, strong cash generation, and shareholder-focused buybacks at a moderate valuation, although reimbursement constraints, slow organic growth, and substantial leverage limit its upside.

Score
78